title: Trial design for metastatic castration-resistant prostate cancer.
authors.forename: Guru
authors.initials: G
authors.lastname: Sonpavde
authors.forename: Mark T
authors.initials: MT
authors.lastname: Fleming
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Hutson
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Galsky
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use; D002369:Castration; D002986:Clinical Trials as Topic / Q000592:standards*; D023381:Endpoint Determination; D017408:Guidelines as Topic; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D012107:Research Design / Q000592:standards*
chemical_list: D000726:Androgen Antagonists; D017430:Prostate-Specific Antigen